Search for: "Bristol-Myers Squibb Company "
Results 381 - 400
of 465
Sort by Relevance
|
Sort by Date
17 Apr 2009, 11:05 am
Such arrangements aren’t unprecedented, though: In 2007, AstraZeneca PLC and Bristol-Myers Squibb Co. struck a partnership to develop and market two diabetes drugs. [read post]
7 Apr 2009, 4:08 am
Andrew Bodnar, a former top executive at Bristol-Myers Squibb Co , faces up to a year in jail after pleading guilty to lying to federal officials about a deal to block a generic version of the company's top-selling medicine.Bodnar, who was a senior vice president of strategy and a member of Bristol's executive committee, was indicted a year ago for misleading statements to the U.S. [read post]
3 Apr 2009, 8:31 am
Case Study – 01 Let us take example of Bristol-Myer Squibb (BMS) patented drug Dasatinib for which Hetero Drugs filed an application with the DCGI for marketing approval of generic dossier of Dasatinib. [read post]
2 Apr 2009, 1:01 pm
In our first post we particularly analyzed that both Bristol-Myer Squibb (BMS) and the Delhi High Court acted within the periphery of the law and the Delhi HC order nowhere created any sort of "patent-drug regulatory" linkage, an argument unnecessarily sensationalized and propagandized by newspaper media. [read post]
20 Mar 2009, 2:05 am
Squibb & Sons, Inc. v. [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
3 Mar 2009, 5:55 am
After plaintiff reported the loss, defendant Erie Insurance Company began an investigation into the claim. [read post]
27 Feb 2009, 9:03 pm
Nonpracticing New Jersey physician Joseph Piacentile "now makes a living suing drug companies," and the new action in which his name figures against Forest Laboratories follows earlier suits he's helped instigate against Medco Health Solutions, Bristol-Myers Squibb, and Cephalon Inc.... [read post]
27 Feb 2009, 7:00 am
(Techdirt) How companies can cash in on innovations and patents (IP Frontline) International Property Rights Index 2009 - New report identifies world’s most IP-friendly country, but trade marks are ignored (IAM) What do clients want? [read post]
23 Feb 2009, 1:44 am
The commercials for Bristol-Myers Squibb's (BMS) new Rheumatoid Arthritis Drug, Orencia (c). [read post]
23 Feb 2009, 1:19 am
The commercials for Bristol-Myers Squibb's (BMS) new Rheumatoid Arthritis Drug, Orencia (c). [read post]
10 Feb 2009, 7:55 am
For other companies, such as Bristol-Myers Squibb, the meeting was more of a listening exercise for board directors. [read post]
31 Jan 2009, 6:54 am
• Bristol-Myers Squibb posted a quarterly profit of $1.24 billion. [read post]
18 Jan 2009, 4:48 pm
Dasatinib is an anti-cancer drug belonging to the class of tyrosine kinase inhibitors first approved in the United States on June 28, 2006 and marketed by Bristol-Myer Squibb (BMS) under the brand name Sprycel. [read post]
15 Jan 2009, 3:35 am
Just to recap then, the High Court of Delhi recently granted an ex parte restraining order in favour of Bristol Myers Squibb restraining the defendants, Hetero Drugs (an Indian generic firm) from manufacturing, selling, distributing, advertising, exporting, offering for sale or in any manner dealing directly or indirectly in any product infringing the plaintiffs product patent covering Dasatinib, a drug used in the treatment of Chronic Myloeid Leukemia. [read post]
13 Jan 2009, 7:43 am
Walden Asset Management is urging the Securities and Exchange Commission to reject requests by Bristol-Myers Squibb and other companies to exclude proposals filed by investors affiliated with California-based activist John Chevedden. [read post]
9 Jan 2009, 10:56 am
" For 2009, Davis also refiled proposals seeking more disclosure about executive compensation (at Bristol-Myers Squibb, Comcast, and Con Edison) and to prohibit stock options, at Continental Airlines, Pfizer, and Verizon. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
15 Dec 2008, 2:00 pm
Shortly after the drug hit the market, Sanofi-Synthelabo, which owns the Plavix patent, and Bristol-Myers Squibb, owner of the Plavix marketing rights, sought and obtained an injunction barring sales of the generic. [read post]
